Related Experiment Videos
Interpretable Machine Learning Framework for Predicting Major Adverse Cardiovascular Events in Rheumatoid Arthritis
Wei-Chen Chiang1, Guan-Ling Lin1, Yu-Sheng Chang2,3
1Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, 9F, Education and Research Building, Shuang Ho Campus No. 301, Yuantong Rd, Zhonghe Dist, New Taipei, 235, Taiwan, 886 2-6620-2589 ext 10927.
Interpretable machine learning models can predict cardiovascular events in rheumatoid arthritis (RA) patients. Random Survival Forest with SHAP analysis offers transparent, personalized risk insights for better RA management.
Area of Science:
- Rheumatology
- Cardiovascular Medicine
- Artificial Intelligence in Healthcare
Background:
- Patients with rheumatoid arthritis (RA) have an elevated risk of major adverse cardiovascular events (MACE).
- The clinical utility of machine learning (ML) for cardiovascular risk prediction in RA is limited by the "black-box" nature of complex algorithms.
Purpose of the Study:
- To develop interpretable survival models for predicting MACE in RA patients.
- To provide transparent and actionable insights for personalized cardiovascular risk management in RA.
Main Methods:
- Utilized data from 2461 RA patients (2011-2022) from the Taipei Medical University Clinical Research Database.
- Compared ML survival models (Random Survival Forest, DeepSurv, Cox-Time) against the Cox proportional hazards model.
- Integrated permutation importance and SHAP (Shapley additive explanations) for model interpretability.
Main Results:
- Random Survival Forest (RSF) exhibited superior performance (C-index: 0.8771, integrated Brier score: 0.0775).
- Key predictors identified include creatinine, conventional synthetic disease-modifying antirheumatic drugs, C-reactive protein, alanine aminotransferase, and age at RA diagnosis.
- SHAP analysis revealed specific protective and risk-increasing effects of medications and laboratory markers.
Conclusions:
- RSF with SHAP analysis provides interpretable and personalized cardiovascular risk predictions for RA patients.
- This approach enhances clinical decision-making and advances precision medicine in rheumatology.
- Future research should focus on temporal and external validation to ensure model generalizability.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease IV: Nursing Management